1. Home
  2. Analysis
  3. Acetazolamide
  4. Nearsightedness

Acetazolamide and Nearsightedness - a phase IV clinical study of FDA data

Summary:

Nearsightedness is reported as a side effect among people who take Acetazolamide (acetazolamide), especially for people who are female, 60+ old, also take Dexamethasone, and have Developmental glaucoma.

The phase IV clinical study analyzes which people have Nearsightedness when taking Acetazolamide. It is created by eHealthMe based on reports of 5,933 people who have side effects when taking Acetazolamide from the FDA, and is updated regularly.

What is Acetazolamide?

Acetazolamide has active ingredients of acetazolamide. It is often used in pseudotumor cerebri. eHealthMe is studying from 6,178 Acetazolamide users. Check the latest studies of Acetazolamide.

What is Nearsightedness?

Nearsightedness (difficulty in seeing the far objects) is found to be associated with 470 drugs and 679 conditions by eHealthMe. Check the latest studies of Nearsightedness.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 11, 2026

5,933 people reported to have side effects when taking Acetazolamide.
Among them, 13 people (0.22%) have Nearsightedness.

Could Acetazolamide cause Nearsightedness?

Among these 13 people:

What is the gender of people who have Nearsightedness when taking Acetazolamide? *

  • female: 66.67 %
  • male: 33.33 %

What is the age of people who have Nearsightedness when taking Acetazolamide? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 16.67 %
  • 20-29: 8.33 %
  • 30-39: 16.67 %
  • 40-49: 25.0 %
  • 50-59: 0.0 %
  • 60+: 33.33 %

What are other drugs people take besides Acetazolamide? *

  1. Dexamethasone: 3 people, 23.08%
  2. Trusopt: 2 people, 15.38%
  3. Travoprost: 2 people, 15.38%
  4. Tropicamide: 1 person, 7.69%
  5. Topiramate: 1 person, 7.69%
  6. Timolol: 1 person, 7.69%
  7. Latanoprost: 1 person, 7.69%
  8. Citalopram Hydrobromide: 1 person, 7.69%

What are other side effects people have besides Nearsightedness? *

  1. Choroidal Detachment (separation of vascular layer of the eye): 4 people, 30.77%
  2. Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest): 3 people, 23.08%
  3. Choroidal Effusion (fluid collection in vascular layer of eye that nourishes retina): 3 people, 23.08%
  4. Angle Closure Glaucoma (term used for several ocular diseases that ultimately result in increased intraocular pressure (iop) and decreased visual acuity): 3 people, 23.08%
  5. Retinal Detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue): 2 people, 15.38%
  6. Drug Ineffective: 2 people, 15.38%
  7. Blindness: 2 people, 15.38%
  8. Lens Dislocation: 1 person, 7.69%
  9. Gastrointestinal Tract Irritation: 1 person, 7.69%
  10. Drug Level Below Therapeutic: 1 person, 7.69%

What are the existing conditions these people have? *

  1. Intraocular Pressure Increased: 2 people, 15.38%
  2. Dyslipidaemia (abnormal amount of lipids): 2 people, 15.38%
  3. Developmental Glaucoma (development of increased pressure within the eyeball): 2 people, 15.38%
  4. Visual Field Defect: 1 person, 7.69%
  5. Retinopathy (acute damage to the retina of the eye): 1 person, 7.69%
  6. Migraine (headache): 1 person, 7.69%
  7. Headache (pain in head): 1 person, 7.69%
  8. Depression: 1 person, 7.69%
  9. Angle Closure Glaucoma (term used for several ocular diseases that ultimately result in increased intraocular pressure (iop) and decreased visual acuity): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Acetazolamide and have Nearsightedness?

- Check whether Nearsightedness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Acetazolamide:

Nearsightedness treatments and more:

How severe was Nearsightedness and when was it recovered:

Expand to all the drugs that have ingredients of acetazolamide:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Acetazolamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nearsightedness:

Browse all the conditions that are associated with Nearsightedness:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on acetazolamide (the active ingredients of Acetazolamide) and Acetazolamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.